How big is the Latin America Insulin Delivery Devices Market?

March 2022: Novo Nordisk announced that two smart connected insulin pens, NovoPen 6 and NovoPen Echo Plus, were available on prescription for people with diabetes treated with Novo Nordisk insulin in the United Kingdom.
January 2022: Boston-based Insulet Corp. announced that the FDA (Food and Drug Administration) cleared the new Omnipod 5 system, marking the company's entry into the automated insulin delivery (AID) universe.

The Latin America Insulin Delivery Devices Market size is expected to reach USD 7.14 million in 2024 and grow at a CAGR of greater than 2% to reach USD 8.16 million by 2029. Read More

What is the current Latin America Insulin Delivery Devices Market size?

In 2024, the Latin America Insulin Delivery Devices Market size is expected to reach USD 7.14 million. Read More

Who are the key players in Latin America Insulin Delivery Devices Market?

Ypsomed, Medtronic, Sanofi, Eli Lilly and Novo Nordisk are the major companies operating in the Latin America Insulin Delivery Devices Market. Read More

What years does this Latin America Insulin Delivery Devices Market cover, and what was the market size in 2023?

In 2023, the Latin America Insulin Delivery Devices Market size was estimated at USD 7 million. The report covers the Latin America Insulin Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Latin America Insulin Delivery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Latin America Insulin Delivery DevicesCompanies

This report lists the top Latin America Insulin Delivery Devices companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Latin America Insulin Delivery Devices industry.